208 related articles for article (PubMed ID: 11602658)
1. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.
Batrakova EV; Li S; Vinogradov SV; Alakhov VY; Miller DW; Kabanov AV
J Pharmacol Exp Ther; 2001 Nov; 299(2):483-93. PubMed ID: 11602658
[TBL] [Abstract][Full Text] [Related]
2. Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.
Batrakova EV; Li S; Alakhov VY; Miller DW; Kabanov AV
J Pharmacol Exp Ther; 2003 Feb; 304(2):845-54. PubMed ID: 12538842
[TBL] [Abstract][Full Text] [Related]
3. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
4. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
5. Effect of pluronic P85 on ATPase activity of drug efflux transporters.
Batrakova EV; Li S; Li Y; Alakhov VY; Kabanov AV
Pharm Res; 2004 Dec; 21(12):2226-33. PubMed ID: 15648254
[TBL] [Abstract][Full Text] [Related]
6. Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier.
Batrakova EV; Zhang Y; Li Y; Li S; Vinogradov SV; Persidsky Y; Alakhov VY; Miller DW; Kabanov AV
Pharm Res; 2004 Nov; 21(11):1993-2000. PubMed ID: 15587920
[TBL] [Abstract][Full Text] [Related]
7. Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.
Zhang X; Alakhova DY; Batrakova EV; Li S; Yang Z; Li Y; Kabanov AV
J Neuroimmune Pharmacol; 2009 Mar; 4(1):35-46. PubMed ID: 18677571
[TBL] [Abstract][Full Text] [Related]
8. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
9. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
10. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.
Batrakova EV; Han HY; Miller DW; Kabanov AV
Pharm Res; 1998 Oct; 15(10):1525-32. PubMed ID: 9794493
[TBL] [Abstract][Full Text] [Related]
11. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.
Liu R; Sharom FJ
Biochemistry; 1998 May; 37(18):6503-12. PubMed ID: 9572868
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion.
Batrakova EV; Li S; Elmquist WF; Miller DW; Alakhov VY; Kabanov AV
Br J Cancer; 2001 Dec; 85(12):1987-97. PubMed ID: 11747344
[TBL] [Abstract][Full Text] [Related]
14. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
He L; Zhao C; Yan M; Zhang LY; Xia YZ
Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
[TBL] [Abstract][Full Text] [Related]
17. Pluronic p85 block copolymer enhances opioid peptide analgesia.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2002 Nov; 303(2):760-7. PubMed ID: 12388663
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
Vilas-Boas V; Silva R; Nunes C; Reis S; Ferreira L; Vieira C; Carvalho F; Bastos Mde L; Remião F
Toxicol Lett; 2013 Jul; 220(3):259-66. PubMed ID: 23685082
[TBL] [Abstract][Full Text] [Related]
19. Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ.
Rice A; Liu Y; Michaelis ML; Himes RH; Georg GI; Audus KL
J Med Chem; 2005 Feb; 48(3):832-8. PubMed ID: 15689167
[TBL] [Abstract][Full Text] [Related]
20. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
